Virtual Reality (VR) Self-Hypnosis Software
RecruitingNot applicableNCT06398847
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.
Study details
- Official title
- An Open-label Study of Self-hypnosis Software for Virtual Reality for the Treatment of HIV-associated Chronic Pain - a Development and Usability Study
- Interventions
- Device: Virtual Reality headset
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start date
- 2026-03-26
- Primary completion
- 2027-06-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Patient Eligibility Inclusion Criteria: * Adults age ≥18 * Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days. * Documentation of chronic pain associated with HIV for≥90 days * Stable pain management regimen ≥90 days, or no pain treatments ≥90 days * Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2 * Access to the internet via smartphone, computer, or tablet 7. Fluent in English * Capable of giving informed consent and willingness to comply with study procedures. Exclusion Criteria: * A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention. * Concurrent participation in another investigational protocol for pain treatment * A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures. * Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices. * A medical condition predisposing prospective participant to nausea or dizziness 6. Lack of stereoscopic vision or severe hearing impairment * Injury to eyes, face, or neck that impedes using the VR device * If participant has access to personal VR gear for gaming or other purposes at home, participant fails to agree not to use these personal VR gear during the course of the protocol. * Currently pregnant or planning to become pregnant during the study period
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06398847